Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure

Area of Science:

• Cardiology
• Nephrology
• Pharmacology

Background:

• Electrolyte abnormalities are prevalent in heart failure patients.
• These imbalances can stem from neurohormonal activation, cardiac dysfunction, renal issues, and medications.
• Disturbances in sodium, chloride, acid-base, and potassium significantly affect heart failure morbidity and mortality.

Purpose of the Study:

• To review the various etiologies of electrolyte abnormalities in heart failure.
• To discuss the spectrum of pharmacological treatments for these imbalances.
• To highlight the importance of understanding both traditional and novel therapeutic strategies.

Main Methods:

• Literature review of established and emerging treatments for electrolyte disturbances in heart failure.
• Analysis of pharmacological approaches targeting electrolyte homeostasis.
• Synthesis of information on neurohormonal antagonism and specific agents.

Main Results:

• Identified key electrolyte disturbances including hyponatremia, hyperkalemia, and acid-base imbalances.
• Cataloged a range of treatments: vaptans, acetazolamide, hypertonic saline, urea, patiromer, and zirconium cyclosilicate.
• Highlighted diverse mechanisms of action, from intake modification to neurohormonal blockade.

Conclusions:

• Effective management of heart failure necessitates addressing electrolyte abnormalities.
• A comprehensive understanding of both historical and novel therapeutic options is essential.
• Continued research and clinical application of these treatments are vital for improving patient prognosis.